Startup profile · funding coverage
Photon Health funding, valuation and investors
AI-native prescription infrastructure and patient-controlled routing platform.
Keep track of Photon Health
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Series A
$16M · April 2026
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$25M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
series a · New York, NY
Overview
Photon Health (Photon) provides end-to-end digital prescribing infrastructure — APIs, pharmacy network, and a patient marketplace so consumers choose pharmacies with price and inventory visibility. Founded by Otto Sipe with Notation Capital as an early backer, Photon raised $16M Series A in April 2026 led by Healthier Capital with Notation, Flare Capital, and Evidenced participating after a $9M round in July 2024.
Why Photon Health is interesting
E-prescribing digitized the script but left patients blind at the pharmacy counter — Photon rebuilds routing with transparency at the moment of care.
Product & use cases
Prescribing tools, pharmacy network integrations, and patient-facing script wallet with routing to in-network and retail pharmacies.
- D2C health brands issuing prescriptions via API
- Health systems driving in-house pharmacy utilization
- Patients comparing pharmacy price and stock at prescribe time
Key facts
- Series A (Apr 2026): $16M led by Healthier Capital
- Notation largest check; early pre-seed lead 2021
- Millions of patients served since 2021 founding
- NYC/Brooklyn team per Notation post
Funding history (newest first)
Series A
2026-04 $16M- Healthier Capital (lead)
- Notation Capital (participant)
- Flare Capital (participant)
Series A (prior)
2024-07 $9MSource: https://medium.com/notation-capital/photon-health-331585f1e0f3
Investors in our directory
Funds linked from Photon Health's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: Notation first-check relationship since 2021 and largest Notation check to date per Medium post; challenger to Surescripts-heavy incumbent stack.
Prescription routing incumbents have network effects; Photon must integrate with prescriber workflows and payers while offering patient transparency wedge. Health system growth cited in Series A press.
-
Surescripts / e-prescribing incumbents incumbent
Dominant routing network with entrenched EHR integrations.
-
Capsule / Alto (delivery pharmacies) adjacent
Fulfillment players without full infra API layer.
-
EHR-native eRx modules incumbent
Basic send-to-pharmacy without patient choice UX.
Notable stories
- Notation's Nicholas Chirls led pre-seed after Otto Sipe left Thirty Madison convinced e-prescribing routing could be rebuilt patient-first.
- Hit Consultant described Photon fixing the 'information vacuum' at prescribe time.
Industries
Related funding articles
Venture Capital Tracker pieces that cover Photon Health's financing or category context.
FAQs about Photon Health
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.